Recently, Overseas Department of YRPG successfully developed African market. Four medicines were sold in Guinea, opening a window for expanding global trade.
After fierce competition with a French medical company, YRPG won the trust of the trade partner Guinea Far East Pharmaceutical Co., Ltd. and went into Guinea market. Those sold to Guinea this time were all generic western medicines, mainly including paracetamol and pseudoephedrine chlorpheniramine tablets (antipyretic and analgesic medicines), fluconazole tablets (antimicrobial medicines), ofloxacin capsules and roxithromycin capsules. The sales amount of the first order is 43,000 dollars. The trade amount is expected to expand continuously in the future.
Guinea is located in the west of Africa. It was used to be the colony of France. It has no medical industry on its own, so medicines and medical apparatus and instruments mainly rely on import. Since this year, YRPG gives full play to the advantages of good quality, quick curative effects and cheapness, timely improves the materials of exported products, properly adjusts the packages and dosage specification, actively participates in the development of Guinea medical market, and breaks through the situation that the imported medicines have been monopolized by western countries for a long time.
YRPG has registered 18 types of medicines in over 10 countries such as Singapore, The Czech Republic, Malaysia, South Africa, Poland and Vietnam. The scale sales are ready for start. Now extracted astragalus oral liquid and ginkgo leaf are sold in Hong Kong. Maleate enalapril tablets are added to the medicine bidding by Hong Kong Department of Health. Approval of crude medicines intended for export and certification of FDA have been started. 2.5 million bottles of Citrate tamoxifen tablets exported to Egypt and nifedipine sustained release tablet exported to Mexico are under preliminary preparation. More and more Chinese medicines and western medicines of YRPG gradually go to the broad international market. (By Li Jiang)